The renin angiotensin system in the development of cardiovascular disease: role of aliskiren in risk reductionPaolo Verdecchia, Giorgio Gentile, Paolo Reboldi et al.|Vascular Health and Risk Management|2008Cited by 95
Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trialsPaolo Reboldi, Verdecchia, Giorgio Gentile et al.|Vascular Health and Risk Management|2009Cited by 51